regulatory
confidence high
sentiment negative
materiality 0.75
ReShape Lifesciences receives Nasdaq delisting notice for stockholders' equity below $2.5M
Vyome Holdings, Inc
- As of Sept 30, 2024, stockholders' equity was $1,487,000, below Nasdaq's $2.5M minimum.
- Company has 45 days to submit a compliance plan; if accepted, Nasdaq may grant up to 180-day extension.
- Intends to monitor performance and consider available options to regain compliance.